Topiramate Tablet, Film Coated
Product Images NDC 51655-746

4 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 51655-746). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Product Formula For Topiramate (27b1bec6 E45f 4ac7 Bbaf 5cd29338432d 01)

Structured Product Formula For Topiramate (27b1bec6 E45f 4ac7 Bbaf 5cd29338432d 01)
Chemical structure diagram of the active ingredient topiramate, showing its molecular configuration including the cyclic and functional groups.*
FDA Label Image

Structured Product Formula For Topiramate (27b1bec6 E45f 4ac7 Bbaf 5cd29338432d 02)

Structured Product Formula For Topiramate (27b1bec6 E45f 4ac7 Bbaf 5cd29338432d 02)
A Kaplan-Meier curve showing cumulative rates for time to first seizure over 500 days comparing Topiramate 50 mg/day versus 400 mg/day. The solid line represents the 50 mg/day group, and the dashed line represents the 400 mg/day group, with a statistical significance of P = 0.0002.*
FDA Label Image

Topiramate Tablets Usp (27b1bec6 E45f 4ac7 Bbaf 5cd29338432d 03)

Topiramate Tablets Usp (27b1bec6 E45f 4ac7 Bbaf 5cd29338432d 03)
A bar chart depicting the change from baseline to double-blind phase in average monthly migraine period rate for placebo and topiramate doses of 50 mg/day, 100 mg/day, and 200 mg/day. Results from two studies (Study 11 and Study 12) are shown with vertical bars and error bars, indicating reductions in migraine rates with increasing topiramate doses compared to placebo.*
FDA Label Image

Label (51655 746 26 Rev A 01 23 Nhc)

Label (51655 746 26   Rev A 01 23 Nhc)
Label for Topiramate Tablets USP 50 mg by Northwind Health Company, LLC. The label indicates a package of 90 film-coated tablets for oral use, marked as prescription only. Storage instructions specify controlled room temperature, and warnings include keeping out of reach of children and protecting from moisture. The label includes an NDC of 51655-746-26.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.